BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24455684)

  • 1. Stat3 upregulates leucine-rich repeat-containing g protein-coupled receptor 4 expression in osteosarcoma cells.
    Liu J; Wei W; Guo CA; Han N; Pan JF; Fei T; Yan ZQ
    Biomed Res Int; 2013; 2013():310691. PubMed ID: 24455684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
    Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
    BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
    Wu Z; Liu J; Hu S; Zhu Y; Li S
    Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible Role of IL-6R/STAT3/MiRNA-34a Feedback Loop in Osteosarcoma.
    Amer MF; Mohamed A; Ismail A; Bayoumi LA; Shibel PEE; Elnaggar GN
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3269-3274. PubMed ID: 37774081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
    Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
    Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway.
    Wang Y; Chu Y; Yue B; Ma X; Zhang G; Xiang H; Liu Y; Wang T; Wu X; Chen B
    Oncotarget; 2017 Apr; 8(14):23803-23816. PubMed ID: 28423603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway.
    Song K; Ma J; Gao Y; Qu Y; Ren C; Yan P; Zheng B; Yue B
    Adv Med Sci; 2022 Sep; 67(2):187-195. PubMed ID: 35398779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
    Zhang S; Wang Y; Chen S; Li J
    Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
    Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
    BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
    Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
    Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP8 activates STAT3 to induce PD-L1 expression in osteosarcoma.
    Zheng S; Wei Y; Jiang Y; Hao Y
    Tumori; 2021 Jun; 107(3):238-246. PubMed ID: 33054597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
    Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines.
    Keremu A; Aimaiti A; Liang Z; Zou X
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):255-264. PubMed ID: 30430228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.